Hims & Hers Health Past Earnings Performance
Past criteria checks 4/6
Hims & Hers Health has been growing earnings at an average annual rate of 57.4%, while the Healthcare industry saw earnings growing at 2.9% annually. Revenues have been growing at an average rate of 49.4% per year. Hims & Hers Health's return on equity is 34.4%, and it has net margins of 9.6%.
Key information
57.41%
Earnings growth rate
63.98%
EPS growth rate
| Healthcare Industry Growth | 8.50% |
| Revenue growth rate | 49.45% |
| Return on equity | 34.41% |
| Net Margin | 9.62% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships
Oct 08Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 33% Share Price Bounce
Sep 27
What You Can Learn From Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S After Its 26% Share Price Crash
Jul 22📈 HIMS' Asymmetric Opportunity, JIN’s Overlooked Strengths, and PROX's Possible Re-Rating
May 21
Hims: The Platform Powering Personalised Healthcare
Platform Play, Not a Pill Company: Hims is building the infrastructure for personalised, direct-to-consumer healthcare across diagnostics, treatment, and prevention, similar to what Amazon did for retHims & Hers Health's (NYSE:HIMS) Performance Is Even Better Than Its Earnings Suggest
May 13After Leaping 89% Hims & Hers Health, Inc. (NYSE:HIMS) Shares Are Not Flying Under The Radar
May 08Hims & Hers Health: GLP-1 Deals De-Risk The Story
Apr 29Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy
Apr 23With A 29% Price Drop For Hims & Hers Health, Inc. (NYSE:HIMS) You'll Still Get What You Pay For
Mar 24Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
Mar 20Hims & Hers' Fall From Grace Is Warranted - Still No Margin Of Safety
Mar 03Hims & Hers: Why This Q4 Earnings Dip Is A Buying Opportunity
Feb 25Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)
Feb 19Hims & Hers Health: Explosive Growth Potential Ahead
Feb 11Market Participants Recognise Hims & Hers Health, Inc.'s (NYSE:HIMS) Revenues Pushing Shares 46% Higher
Feb 04Hims & Hers: Potential Risks Ahead, But Shorting May Be Premature
Jan 29Hims & Hers Health: The Market Is Likely Wrong
Jan 19Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns
Jan 09Hims & Hers: Ready For Liftoff In 2025
Jan 02Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It Lasted
Dec 19Hims & Hers: Look At What Matters Most
Dec 12Hims & Hers: The Show Must Go On
Dec 05Hims & Hers: Driving Growth In Wellness
Nov 29Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 44% Share Price Surge
Nov 26Hims & Hers Health: The Amazon Curse Is Being Overstated
Nov 15Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
Nov 05Revenue & Expenses Breakdown
How Hims & Hers Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 2,014 | 194 | 1,291 | 113 |
| 31 Mar 25 | 1,784 | 164 | 1,166 | 93 |
| 31 Dec 24 | 1,477 | 126 | 1,028 | 79 |
| 30 Sep 24 | 1,242 | 101 | 893 | 68 |
| 30 Jun 24 | 1,067 | 18 | 802 | 60 |
| 31 Mar 24 | 959 | -2 | 743 | 53 |
| 31 Dec 23 | 872 | -24 | 693 | 48 |
| 30 Sep 23 | 793 | -36 | 639 | 43 |
| 30 Jun 23 | 711 | -47 | 581 | 39 |
| 31 Mar 23 | 616 | -59 | 514 | 34 |
| 31 Dec 22 | 527 | -66 | 446 | 29 |
| 30 Sep 22 | 444 | -86 | 381 | 26 |
| 30 Jun 22 | 374 | -83 | 324 | 35 |
| 31 Mar 22 | 321 | -73 | 281 | 28 |
| 31 Dec 21 | 272 | -108 | 289 | 22 |
| 30 Sep 21 | 229 | -82 | 250 | 17 |
| 30 Jun 21 | 196 | -72 | 217 | 0 |
| 31 Mar 21 | 171 | -63 | 186 | 0 |
| 31 Dec 20 | 149 | -18 | 113 | 11 |
| 30 Sep 20 | 132 | -25 | 117 | 0 |
| 30 Jun 20 | 112 | -38 | 114 | 0 |
| 31 Mar 20 | 95 | -58 | 117 | 0 |
| 31 Dec 19 | 83 | -72 | 119 | 0 |
| 31 Dec 18 | 27 | -75 | 84 | 0 |
Quality Earnings: HIMS has a high level of non-cash earnings.
Growing Profit Margin: HIMS's current net profit margins (9.6%) are higher than last year (1.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HIMS has become profitable over the past 5 years, growing earnings by 57.4% per year.
Accelerating Growth: HIMS's earnings growth over the past year (969.5%) exceeds its 5-year average (57.4% per year).
Earnings vs Industry: HIMS earnings growth over the past year (969.5%) exceeded the Healthcare industry 10.4%.
Return on Equity
High ROE: Whilst HIMS's Return on Equity (34.41%) is high, this metric is skewed due to their high level of debt.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/10 10:06 |
| End of Day Share Price | 2025/10/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hims & Hers Health, Inc. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Allen Lutz | BofA Global Research |
| Allen Lutz | BofA Global Research |